Hidehiko Hara, Shunsuke Kubo, Yoshifumi Nakajima, Takashi Matsumoto, Yusuke Kondo, Hiroki Sugane, Kenji Okubo, Koji Nakagawa, Daisuke Nagatomo, Daisuke Hachinohe, Shigeki Kusa, Masahiko Goya, Mamoru Nanasato, Takeshi Arita, Hiro Yamasaki, Kensuke Kuwabara, Tomotaka Yoshiyama, Nobuaki Tanaka, Masaharu Masuda, Tomohiro Sakamoto, Masaki Nakashima, Yohei Ohno, Shigeru Saito, Masato Fukunaga
BACKGROUND: Percutaneous left atrial appendage closure (LAAC) has increased for those who need alternative to long-term anticoagulation with non-valvular atrial fibrillation (NVAF). METHODS AND RESULTS: From September 2019, after initiating WATCHMAN (Boston Scientific, Maple Grove, MN, USA) device implantation, we established Transcatheter Modification of Left Atrial Appendage by Obliteration with Device in Patients from the NVAF (TERMINATOR) registry. Utilizing 729 patients' data until January 2022, we analyzed percutaneous LAAC data regarding this real-world multicenter prospective registry...
October 5, 2023: Journal of Cardiology